[1]
KUMARI, K.V. et al. 2025. A STUDY TO EVALUATE THE EFFECT OF EMPAGLIFLOZIN ON CARDIOVASCULAR AND RENAL OUTCOMES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AT A TERTIARY CARE HOSPITAL IN TELANGANA. International Journal of Pharmacy and Pharmaceutical Sciences. 17, 3 (Mar. 2025), 10–15. DOI:https://doi.org/10.22159/ijpps.2025v17i3.53190.